Human ICAM-1 FlowCytomix Simplex

Also known as: Intercellular adhesion molecule 1, CD54 antigen

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# BMS80201FF*

Cat. No. Size
BMS80201FF 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human ICAM-1 FlowCytomix Simplex.

Click on image to view more information.

  • Data for Human ICAM-1 FlowCytomix Simplex.
Description

Description: This FlowCytomix Simplex Kit is designed for the measurement of Human sICAM-1 in an immunoassay analyzed on a flow cytometer. Together with the FlowCytomix Human Basic Kit PE (cat. BMS8421FF), this kit can be used to detect sICAM-1 alone or can be multiplexed with other Simplex Kits to measure a variety of analytes.

This kit contains bead population A11.

Intercellular Adhesion Molecule-1 (ICAM-1) is a member of the immunoglobulin supergene family and functions as a ligand for the Lymphocyte Function-Associated Antigen-1 (LFA-1), an alpha-beta-complex that is a member of the leukocyte integrin family of cell-cell and cell-matrix receptors. This family consists of the leukocyte adhesion glycoproteins LFA-1 which mediates lymphocyte adhesion, Mac-1 which mediates granulocyte adhesion and p150,95.

ICAM-1 is a single-chain glycoprotein with a polypeptide core that can be expressed on non-hematopoietic cells of many lineages such as vascular endothelial cells, thymic epithelial cells, other epithelial cells and fibroblasts and on hematopoietic cells such as tissue macrophages, mitogen-stimulated T-lymphoblasts, germinal center B-cells and dendritic cells in tonsils, lymph nodes and Peyer's patches. ICAM-1 is inducible on fibroblasts and endothelial cells by inflammatory mediators such as IL-1, TNF and IFN-gamma within few hours and is correlated to the infiltration of lymphocytes into inflammatory lesions. ICAM-1 seems to be the initial marker of inflammatory reactions and is expressed prior to, and to a greater extent than is HLA-DR.

The role of ICAM-1 as a disease marker has been demonstrated for a number of different indications and pathological situations.

Details
Reactivity Human
Sample Volume 25 uL
Suitable Sample Types cell culture supernatant, serum, plasma (citrate)
Sensitivity 5.3 ng/mL
Standard Curve Range 5.0 - 4,000 ng/mL
Components 1 vial (175 ul) Fluorescent Beads (20x) coated with monoclonal antibody to human sICAM-1, Bead Population A11
2 vials human sICAM-1 Standard (lyophilized): 80 ug/ml upon reconstitution
1 vial (350 ul) PE-Conjugate (20x) anti-human sICAM-1 monoclonal antibody
Reported Applications Multiplex Immunoassay
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
BMS205INST* Human sE-selectin Instant ELISA ELISA RUO
BMS232* Human sVCAM-1 Platinum ELISA ELISA RUO
BMS236* Human sICAM-2 Platinum ELISA ELISA RUO
BMS241* Human sICAM-1 Platinum ELISA (extra sensitive) ELISA RUO
BMS812FF* Human Adhesion 6plex FlowCytomix Multiplex Multiplex RUO
References

Citations: Wong,C.K.; Ho,A.W.; Tong,P.C.; Yeung,C.Y.; Chan,J.C.; Kong,A.P.; Lam,C.W.. Aberrant expression of soluble co-stimulatory molecules and adhesion molecules in type 2 diabetic patients with nephropathy. J Clin Immunol 2008;28:36-43. (Link)

Michlmayr A.,S.Baumann,M.Zellner,C.Burghuber,P.Schuch,C.Wenzel,R.Bartsch,U.Pluschnig,I.Rech-Weichselbraun,G.Steger,R.Jakesz,M.Gnant and T.Bachleitner-Hofmann,M.Bergmann,R.Oehler. Chemotherapy induces inflammatory response in breast cancer patients. Keystonesymposia, Inflammation, Microenvironment and Cancer 2008;

References: Rothlein,R.; Mainolfi,E.A.; Czajkowski,M.; Marlin,S.D.. A form of circulating ICAM-1 in human serum. J.Immunol. 1991;147:3788-3793. (Link)

Altomonte,M.; Colizzi,F.; Esposito,G.; Maio,M.. Circulating intercellular adhesion molecule 1 as a marker of disease progression in cutaneous melanoma. N Engl.J.Med. 1992;327:959(Link)

Salafia,C.M.; DeVore,G.R.; Mainolfi,E.; Kelly,J.; Pezzullo,J.C.; Rothlein,R.. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation. Am.J.Obstet.Gynecol. 1993;830-834. (Link)

Pober,J.S.; Gimbrone,M.A.,Jr.; Lapierre,L.A.; Mendrick,D.L.; Fiers,W.; Rothlein,R.; Springer,T.A.. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J.Immunol. 1986;137:1893-1896. (Link)

Dustin,M.L.; Rothlein,R.; Bhan,A.K.; Dinarello,C.A.; Springer,T.A.. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J.Immunol. 1986;137:245-254. (Link)

Lampeter,E.R.; Kishimoto,T.K.; Rothlein,R.; Mainolfi,E.A.; Bertrams,J.; Kolb,H.; Martin,S.. Elevated levels of circulating adhesion molecules in IDDM patients and in subjects at risk for IDDM. Diabetes 1992;41:1668-1671. (Link)

Vejlsgaard,G.L.; Ralfkiaer,E.; Avnstorp,C.; Czajkowski,M.; Marlin,S.D.; Rothlein,R.. Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J.Am.Acad.Dermatol. 1989;20:782-790. (Link)

Lal,R.B.; Mainolfi,E.; Rothlein,R.. Elevated levels of cICAM-1 in patients with human T-cell leukemia virus type I associated myelopathy and adult T-cell leukemia. Blood 1992;80:2434-2435. (Link)

Salafia,C.M.; DeVore,G.R.; Mainolfi,E.; Kelly,J.; Pezzullo,J.C.; Rothlein,R.. Circulating intercellular adhesion molecule-1 in amniotic fluid, maternal serum alpha-fetoprotein levels, and intrauterine growth retardation. Am.J.Obstet.Gynecol. 1993;169:830-834. (Link)

Most,J.; Zangerle,R.; Herold,M.; Fuchs,D.; Wachter,H.; Fritsch,P.; Dierich,M.P.. Elevated concentrations of circulating intercellular adhesion molecule 1 (ICAM-1) in HIV-1 infection. J.Acquir.Immune Defic.Syndr. 1993;6:221-226. (Link)

Lisby,S.; Ralfkiaer,E.; Rothlein,R.; Vejlsgaard,G.L.. Intercellular adhesion molecule-I (ICAM-I) expression correlated to inflammation. Br.J.Dermatol. 1989;120:479-484. (Link)

Rothlein,R.; Dustin,M.L.; Marlin,S.D.; Springer,T.A.. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J.Immunol. 1986;137:1270-1274. (Link)

Harning,R.; Mainolfi,E.; Bystryn,J.C.; Henn,M.; Merluzzi,V.J.; Rothlein,R.. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 1991;51:5003-5005. (Link)

Adams,D.H.; Hubscher,S.G.; Shaw,J.; Rothlein,R.; Neuberger,J.M.. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 1989;2:1122-1125. (Link)

Potocnik,A.J.; Kinne,R.; Menninger,H.; Zacher,J.; Emmrich,F.; Kroczek,R.A.. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand.J.Immunol. 1990;31:213-224. (Link)

Becker,J.C.; Dummer,R.; Schwinn,A.; Hartmann,A.A.; Burg,G.. Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J.Immunother.(1991.) 1992;12:147-150. (Link)

Marlin,S.D.; Springer,T.A.. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-819. (Link)

Adams,D.H.; Mainolfi,E.; Elias,E.; Neuberger,J.M.; Rothlein,R.. Detection of circulating intercellular adhesion molecule-1 after liver transplantation--evidence of local release within the liver during graft rejection. Transplantation 1993;55:83-87. (Link)

Rothlein,R.; Czajkowski,M.; O'Neill,M.M.; Marlin,S.D.; Mainolfi,E.; Merluzzi,V.J.. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J.Immunol. 1988;141:1665-1669. (Link)

Wegner,C.D.; Gundel,R.H.; Reilly,P.; Haynes,N.; Letts,L.G.; Rothlein,R.. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459. (Link)